Deal Announcements

Parasol Therapeutics Nets New Venture Capital Financing

Friday, April 24, 2009 5:50:00 AM PDT | VentureDeal Staff

Waltham, Massachusetts  --  Pharmaceutical company Parasol Therapeutics has garnered $3.25 million in a new round of venture capital funding.

Parasol is a stealth stage company involved in pharmaceutical drug research and development.

Investors in the round included Polaris Venture Partners, Flagship Ventures and Lux Capital. Proceeds purposes from the financing were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1